Overview

A Clinical Study to Evaluate the Pharmacokinetics and Safety of CKD-396

Status:
Not yet recruiting
Trial end date:
2020-07-16
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the pharmacokinetics and safety of CKD-396.
Phase:
Phase 1
Details
Lead Sponsor:
Chong Kun Dang Pharmaceutical